EN
HI
Summary
As of 12 Oct, 2026, Emcure Pharmaceuticals stock price is ₹1876.8. During the trading session, the stock has moved between an intraday low of ₹1826.10 and an intraday high of ₹1896.50. Over the last 52 weeks, Emcure Pharmaceuticals has traded between ₹1306.50 and ₹2100.70.
The stock has recorded a trading volume of 39,952 shares,. Its Average Traded Price (ATP) is ₹1871.32, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹1876.80.
Emcure Pharmaceuticals has an upper circuit limit of ₹2016.80 and a lower circuit limit of ₹1650.20. The total value traded stands at ₹7.48 CR, and the delivery percentage for the day is 47.12%.
The stock is currently traded with a market lot size of 1. Emcure Pharmaceuticals also offers a dividend yield of 0.2%.
Emcure Pharmaceuticals Share Price Chart
Emcure Pharmaceuticals Share Key Metrics
Volume
39952.00
Market Cap
34783.45 CR
LTQ@LTP
1@1876.80
ATP
1871.32
Var Margin
16.21 %
Circuit Range
1650.2-2016.8
Delivery %
47.12 %
Value
7.48 CR
ASM/GSM
No
Market Lot
1
Emcure Pharmaceuticals Fundamentals
P/E Ratio
34.42
P/B Ratio
6.66
Div. Yield
0.2
Sector P/E
41.33
Sector P/B
3.45
Sec. Div. Yield
0.53
Emcure Pharmaceuticals Resistance and Support
Pivot 1849.53
Resistance
First Resistance
1882.96
Second Resistance
1932.43
Third Resistance
1965.86
Support
First Support
1800.06
Second Support
1766.63
Third Support
1717.16
Emcure Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Oct 12 2026 | 1828.1 | 1876.8 | 2.36% | 1896.5 | 1826.1 |
| Fri Oct 09 2026 | 1864.69 | 1833.5 | -0.97% | 1899 | 1816.09 |
| Thu Oct 08 2026 | 1905.09 | 1851.5 | -3.47% | 1919.5 | 1838 |
Emcure Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-05 | Audited Results & Final Dividend |
| 2026-02-04 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-06 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Emcure Pharmaceuticals News
Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015 - Change In Composition Of The Board Of The Company
Emcure Pharmaceuticals shareholders approved the re-appointment of Mr. Satish Mehta as Managing Director & CEO for a further five years, effective April 1, 2027. This decision was made at the 45th Annual General Meeting.
Sep 23 2026 18:28:11
Emcure Pharmaceuticals Management
| Name | Position |
|---|---|
| Berjis Desai | Chairman |
| Satish Mehta | Managing Director & Chief Executive Officer |
Emcure Pharmaceuticals Similar Stocks
Anthem Biosciences Ltd.
875.85
13.55 (1.57%)
Ipca Laboratories Ltd.
1924.10
8.70 (0.45%)
Ajanta Pharma Ltd.
3394.00
-16.10 (0.47%)
Glaxosmithkline Pharmaceuticals Ltd.
2545.00
4.70 (0.19%)
Narayana Hrudayalaya Ltd.
1713.20
-6.30 (0.37%)
Global Health Ltd.
1308.30
-4.40 (0.34%)
Wockhardt Ltd.
1984.00
-12.40 (0.62%)
Sai Life Sciences Ltd.
1497.00
9.10 (0.61%)
Dr. Lal Pathlabs Ltd.
1972.20
38.60 (2.00%)
Emcure Pharmaceuticals FAQs
The Buying Price of Emcure Pharmaceuticals share is 1876.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Emcure Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Emcure Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Emcure Pharmaceuticals shares is 34.42. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Emcure Pharmaceuticals shares is 6.66. Useful to assess the stock's value relative to its book value.
To assess Emcure Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.33 & 3.45 with sector averages, along with growth rates and financial metrics.
The Market Cap of Emcure Pharmaceuticals is 34783.45 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Emcure Pharmaceuticals share price is 2100.70 & 1306.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Emcure Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in EMCURE
